CIP2A and triple-negative breast carcinoma: In triple-negative breast cancer, activated TGF-β/Smad4 signaling significantly increases the mRNA level of 4E-BP1, which inhibits the translation of the micro-peptide CIP2A-BP by binding it to eIF4F [5].